{'fraction_non_alphanumeric': 0.0513595166163142, 'fraction_numerical': 0.05060422960725076, 'mean_word_length': 4.135658914728682, 'pattern_counts': {'":': 0, '<': 3, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The metabolic syndrome in type 2 diabetic subjects in Gorgan, Iran.

OBJECTIVE
To assess the prevalence of the metabolic syndrome in subjects diagnosed with Type 2 diabetes in Gorgan, Iran.


METHODS
Data were collected from 200 subjects with Type 2 diabetes mellitus and they were categorized as with or without the metabolic syndrome. Metabolic syndrome was diagnosed using Adult Treatment Panel-III (ATP-III) guidelines.


RESULTS
The overall metabolic syndrome prevalence was 51.50%. The mean age of all the subjects was 53.65 +/- 9.50 years. There were 122 females and 78 males of whom 65 females and 38 males had the metabolic syndrome. The mean duration of diabetes was 7.70 +/- 1.29 years. Mean triglycerides were 185.15 +/- 56.63 mg/dl, and fasting blood glucose 153 +/- 19.6 mg/dl. These levels were significantly higher in the subjects with type-2 diabetes with metabolic syndrome, but the mean HDL-cholesterol was 37.96 +/- 5.09 mg/dl and this was lower (p < 0.001). Female and male subjects with metabolic syndrome had significantly longer (except HDL-cholesterol) duration of diabetes, higher Triglyceride, and fasting blood glucose levels (p < 0.001, p < 0.05).


CONCLUSION
This study showed a high prevalence of the metabolic syndrome in subjects with type 2 diabetes. Females were more affected than males.